Skip to content
Search

Latest Stories

Bangladesh government announces hefty allocation for 10 mega projects in Budget 2021-22

Bangladesh government announces hefty allocation for 10 mega projects in Budget 2021-22

IN the national budget for fiscal year 2021-22, Bangladesh government has proposed a hefty allocation of Tk2.25 trillion (£18.7billion) for the Annual Development Program (ADP) that includes its 10 mega projects.

In the ADP, Rooppur Nuclear Power Plant tops the list with a proposed allocation of Tk184.26bn (£1.5bn) followed by Matarbari ultra super critical coal-fired power plant with Tk61.62bn (£513.6 million).


A sum of Tk50.54bn (£421.2m) has been set aside for the Primary Education Development Program (PEDP 4), and Tk48bn (£399.9m) for Dhaka Mass Rapid Transit Development Project (Line 6).

Besides, the Padma Bridge Rail Link has a proposed allocation of Tk38.23bn (£318.6m), Bangabandhu Sheikh Mujib Railway Bridge Tk35.8bn (£298.3m), and the Padma Bridge Tk35 bn (£291.6m).

The expansion project of Hazrat Shahjalal International Airport in Dhaka will get Tk28.27bn (£235.6m) in the new budget, according to the proposal.

Finance Minister AHM Mustafa Kamal placed the proposal for FY2021-22 national budget in parliament on Thursday (3) afternoon.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less